Forkhead Box M1 (FoxM1) Gene Is a New STAT3 Transcriptional Factor Target and Is Essential for Proliferation, Survival and DNA Repair of K562 Cell Line

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Mencalha, André L ^a   Binato, Renata ^a   Ferreira, Gerson M ^a   Du Rocher, Barbara ^a   Abdelhay, Eliana ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXM1; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CELL STRAIN K 562; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA REPAIR; GEL MOBILITY SHIFT ASSAY; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DNA REPAIR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; STAT3 TRANSCRIPTION FACTOR;

EID: 84868089777     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048160     Document Type: Article

References (45)

1. Le Lay J, Kaestner KH, (2010) The Fox genes in the liver: from organogenesis to functional integration. Physiol Rev 90: 1-22.
2. Wang M, Gartel AL, (2011) The suppression of FOXM1 and its targets in breast cancerxenograft tumors by siRNA. Oncotarget 2: 1218-26.
3. Yoshida Y, Wang IC, Yoder HM, Davidson NO, Costa RH, (2007) The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer. Gastroenterology132: 1420-31.
4. Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, et al. (2006) The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 66: 2153-61.
5. Priller M, Pöschl J, Abrão L, von Bueren AO, Cho YJ, et al. (2011) Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients. Clin Cancer Res 17: 6791-801.
6. Liu M, Dai B, Kang SH, Ban K, Huang FJ, et al. (2006) FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res 66: 3593-602.
7. Wang Z, Banerjee S, Kong D, Li Y, Sarkar FH, (2007) Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res 67: 8293-300.
8. Nakamura S, Hirano I, Okinaka K, Takemura T, Yokota D, et al. (2010) The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia. Carcinogenesis 31: 2012-21.
9. Carr JR, Park HJ, Wang Z, Kiefer MM, Raychaudhuri P, (2010) FoxM1 mediates resistance to herceptin and paclitaxel. Cancer Res 70: 5054-63.
10. Yang DK, Son CH, Lee SK, Choi PJ, Lee KE, et al. (2009) Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance. Hum Pathol 40: 464-70.
11. Martin KJ, Patrick DR, Bissell MJ, Fournier MV, (2008) Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets. PLoS One 20: e2994.
12. Katoh Y, Katoh M, (2005) Hedgehog signaling pathway and gastric cancer. Cancer Biol Ther 4: 1050-4.
13. Douard R, Moutereau S, Pernet P, Chimingqi M, Allory Y, et al. (2006) Sonic Hedgehog-dependent proliferation in a series of patients with colorectal cancer. Surgery 139: 665-70.
14. Laurendeau I, Ferrer M, Garrido D, D'Haene N, Ciavarelli P, et al. (2010) Gene expression profiling of the hedgehog signaling pathway in human meningiomas. Mol Med 16: 262-70.
15. Katoh Y, Katoh M, (2009) Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med 9: 873-86.
16. Ma RY, Tong TH, Cheung AM, Tsang AC, Leung WY, et al. (2005) Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J Cell Sci 118: 795-806.
17. Ma RY, Tong TH, Leung WY, Yao KM, (2010) Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1. Methods Mol Biol 647: 113-23.
18. Masuda M, Wakasaki T, Suzui M, Toh S, Joe AK, et al. (2010) Stat3 orchestrates tumor development and progression: the Achilles' heel of head and neck cancers? Curr Cancer Drug Targets 10: 117-26.
19. Mencalha AL, Du Rocher B, Salles D, Binato R, Abdelhay E, (2010) LLL-3, a STAT3 inhibitor, represses BCR-ABL-positive cell proliferation, activates apoptosis and improves the effects of Imatinib mesylate. Cancer Chemother Pharmacol 65: 1039-46.
20. Coppo P, Flamant S, De Mas V, Jarrier P, Guillier M, et al. (2006) BCR-ABL activates STAT3 via JAK and MEK pathways in human cells. Br J Haematol. 134: 171-9.
21. Sengupta A, Banerjee D, Chandra S, Banerji SK, Ghosh R, et al. (2007) Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia 21: 949-55.
22. Barré B, Vigneron A, Coqueret O, (2005) The STAT3 transcription factor is a target for the Myc and riboblastoma proteins on the Cdc25A promoter. J Biol Chem. 280: 15673-81.
23. Teh MT, Wong ST, Neill GW, Ghali LR, Philpott MP, et al. (2002) FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res 62: 4773-80.
24. Pilarsky C, Wenzig M, Specht T, Saeger HD, Grützmann R, (2004) Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 6: 744-50.
25. Cilloni D, Saglio G (2012) Molecular Pathways: BCR-ABL. Clin Cancer Res. In press.
26. Bewry NN, Nair RR, Emmons MF, Boulware D, Pinilla-Ibarz J, et al. (2008) Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance. Mol Cancer Ther 7: 3169-75.
27. Leung TW, Lin SS, Tsang AC, Tong CS, Ching JC, et al. (2001) Over-expression of FoxM1 stimulates cyclin B1 expression. FEBS Lett 507: 59-66.
28. Bicknell KA, (2005) Forkhead (FOX) transcription factors and the cell cycle: measurement of DNA binding by FoxO and FoxM transcription factors. Methods Mol Biol 296: 247-62.
29. Chetty C, Bhoopathi P, Rao JS, Lakka SS, (2009) Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells. Int J Cancer 124: 2468-77.
30. Wang IC, Chen YJ, Hughes DE, Ackerson T, Major ML, et al. (2008) FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem 283: 20770-8.
31. Fu Z, Malureanu L, Huang J, Wang W, Li H, et al. (2008) Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression. Nat Cell Biol 10: 1076-82.
32. Pietenpol JA, Stewart ZA, (2002) Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 181-182: 475-81.
33. Cancer Genome Atlas Research Network, (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474: 609-15.
34. Laoukili J, Kooistra MR, Brás A, Kauw J, Kerkhoven RM, et al. (2005) FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 7: 126-36.
35. Teh MT, Gemenetzidis E, Chaplin T, Young BD, Philpott MP, (2010) Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes. Mol Cancer 9: 45.
36. Bau DT, Mau YC, Shen CY, (2006) The role of BRCA1 in non-homologous end-joining. Cancer Lett 240: 1-8.
37. Leber B, (2011) cml biology for the clinician in 2011: six impossible things to believe before breakfast on the way to cure. Curr Oncol 18: e185-90.
38. Skorski T, (2008) BCR/ABL, DNA damage and DNA repair: implications for new treatment concepts. Leuk Lymphoma 49: 610-4.
39. Long B, Zhu H, Zhu C, Liu T, Meng W, (2011) Activation of the Hedgehog pathway in chronic myelogeneous leukemia patients. J Exp Clin Cancer Res 30: 8.
40. Klein E, Ben-Bassat H, Neumann H, Ralph P, Zeuthen J, et al. (1976) Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer 18: 421-31.
41. Binato R, Mencalha A, Pizzatti L, Scholl V, Zalcberg I, et al. (2009) RUNX1T1 is overexpressed in imatinib mesylate-resistant cells. Mol Med Report 2: 657-61.
42. Livak KJ, Schmittgen T D, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25: 402-408.
43. Nelson JD, Denisenko O, Bomsztyk K, (2006) Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat Protoc 1: 179-85.
44. Turner SD, Ricci AR, Petropoulos H, Genereaux J, Skerjanc IS, et al. (2002) The E2 ubiquitin conjugase Rad6 is required for the ArgR/Mcm1 repression of ARG1 transcription. Mol Cell Biol 22: 4011-9.
45. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, et al. (2005) Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 25: 10875-94.